LCN Stock Overview
Labocanna S.A. engages in the cultivation, production, and distribution of hemp product.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Labocanna S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł0.43 |
| 52 Week High | zł0.84 |
| 52 Week Low | zł0.31 |
| Beta | 2.78 |
| 1 Month Change | -6.54% |
| 3 Month Change | 16.58% |
| 1 Year Change | -13.51% |
| 3 Year Change | -85.60% |
| 5 Year Change | n/a |
| Change since IPO | -68.46% |
Recent News & Updates
Shareholder Returns
| LCN | PL Pharmaceuticals | PL Market | |
|---|---|---|---|
| 7D | -2.5% | -0.5% | -0.3% |
| 1Y | -13.5% | -7.9% | 22.6% |
Return vs Industry: LCN underperformed the Polish Pharmaceuticals industry which returned -7.9% over the past year.
Return vs Market: LCN underperformed the Polish Market which returned 22.6% over the past year.
Price Volatility
| LCN volatility | |
|---|---|
| LCN Average Weekly Movement | 18.8% |
| Pharmaceuticals Industry Average Movement | 4.8% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in PL Market | 9.9% |
| 10% least volatile stocks in PL Market | 3.2% |
Stable Share Price: LCN's share price has been volatile over the past 3 months.
Volatility Over Time: LCN's weekly volatility has increased from 11% to 19% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 5 | n/a | labocanna.pl |
Labocanna S.A. engages in the cultivation, production, and distribution of hemp product. The company also offers food and medical hemp-derived products, as well as CBD hemp oil under the Labocanna brand name. Its products are used in cosmetics, plastics, and textiles.
Labocanna S.A. Fundamentals Summary
| LCN fundamental statistics | |
|---|---|
| Market cap | zł8.86m |
| Earnings (TTM) | -zł598.72k |
| Revenue (TTM) | zł16.52k |
550.5x
P/S Ratio-15.2x
P/E RatioIs LCN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LCN income statement (TTM) | |
|---|---|
| Revenue | zł16.52k |
| Cost of Revenue | zł21.58k |
| Gross Profit | -zł5.06k |
| Other Expenses | zł593.65k |
| Earnings | -zł598.72k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 10, 2024
| Earnings per share (EPS) | -0.028 |
| Gross Margin | -30.66% |
| Net Profit Margin | -3,624.65% |
| Debt/Equity Ratio | 0% |
How did LCN perform over the long term?
See historical performance and comparison